Suppr超能文献

黄病毒NS蛋白的结构与功能:药物设计的前景

Structure and functionality in flavivirus NS-proteins: perspectives for drug design.

作者信息

Bollati Michela, Alvarez Karin, Assenberg René, Baronti Cécile, Canard Bruno, Cook Shelley, Coutard Bruno, Decroly Etienne, de Lamballerie Xavier, Gould Ernest A, Grard Gilda, Grimes Jonathan M, Hilgenfeld Rolf, Jansson Anna M, Malet Hélène, Mancini Erika J, Mastrangelo Eloise, Mattevi Andrea, Milani Mario, Moureau Grégory, Neyts Johan, Owens Raymond J, Ren Jingshan, Selisko Barbara, Speroni Silvia, Steuber Holger, Stuart David I, Unge Torsten, Bolognesi Martino

机构信息

Department of Biomolecular Sciences and Biotechnology, University of Milano, Via Celoria 26, 20133 Milano, Italy.

出版信息

Antiviral Res. 2010 Aug;87(2):125-48. doi: 10.1016/j.antiviral.2009.11.009. Epub 2009 Nov 27.

Abstract

Flaviviridae are small enveloped viruses hosting a positive-sense single-stranded RNA genome. Besides yellow fever virus, a landmark case in the history of virology, members of the Flavivirus genus, such as West Nile virus and dengue virus, are increasingly gaining attention due to their re-emergence and incidence in different areas of the world. Additional environmental and demographic considerations suggest that novel or known flaviviruses will continue to emerge in the future. Nevertheless, up to few years ago flaviviruses were considered low interest candidates for drug design. At the start of the European Union VIZIER Project, in 2004, just two crystal structures of protein domains from the flaviviral replication machinery were known. Such pioneering studies, however, indicated the flaviviral replication complex as a promising target for the development of antiviral compounds. Here we review structural and functional aspects emerging from the characterization of two main components (NS3 and NS5 proteins) of the flavivirus replication complex. Most of the reviewed results were achieved within the European Union VIZIER Project, and cover topics that span from viral genomics to structural biology and inhibition mechanisms. The ultimate aim of the reported approaches is to shed light on the design and development of antiviral drug leads.

摘要

黄病毒科是一类包膜病毒,其基因组为单股正链RNA。除了病毒学史上具有里程碑意义的黄热病病毒外,黄病毒属的成员,如西尼罗河病毒和登革热病毒,由于在世界不同地区再度出现且发病率上升,越来越受到关注。其他环境和人口因素表明,新型或已知的黄病毒在未来将继续出现。然而,直到几年前,黄病毒还被认为是药物设计中不太受关注的候选对象。在2004年欧盟VIZIER项目启动时,黄病毒复制机制中蛋白质结构域的晶体结构只有两个已知。然而,这些开创性的研究表明,黄病毒复制复合体是开发抗病毒化合物的一个有前景的靶点。在这里,我们综述了黄病毒复制复合体两个主要成分(NS3和NS5蛋白)的结构和功能特征。大部分综述结果是在欧盟VIZIER项目中取得的,涵盖了从病毒基因组学到结构生物学和抑制机制等多个主题。所报道方法的最终目的是为抗病毒药物先导物的设计和开发提供思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/3918146/776667cb2c46/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验